Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results, page-9

Just to give a perspective on this Hervaxx results and the significance of it.

As those of us who have been on this journey, we all know that every drug have a fixed patent life. After which, biosims will be able to come to market to compete against the original. Consider this. If biosims think it worthwhile to try and just get a small piece of the market from the original, what do you think it will be worth for a drug that can totally take over the whole market of another by being better, safer and cheaper?

And here, we are talking about Herceptin's multi-billion dollars market. And here, we are talking about just ONE drug candidate out of a potential myriads of drug candidates that IMU will have.

The above is how I see IMU now. It is going to be big. Really big. All in my very excited opinion only